|
|
| ||
|---|---|---|---|
Observing Form - Defining Function:Quantitative Imaging Cytometry inPathology Research and Practice |
| ||
|
Monday, January 29, 2007 Toronto General Hospital The Medical Education Conference Room (025/026) Eaton Wing, Ground Floor 200 Elizabeth Street Toronto, ON, Canada |
|||
“Whole Slide Imaging: A Multicoloured Landscape Viewed from Different Platforms” – Doug Tkachuk, MD, Department of Laboratory Medicine and Pathobiology, University of Toronto, Hematopathologist,University Health Network |
|||
|
“Cellular Life as a Biochemical Finite State Machine: Implications for Cell Based Assays” - James Jacobberger, PhD, Professor of Oncology, Associate Director for Shared Resources, Director Cytometry Core, Case Comprehensive Cancer Center, Cleveland OH |
|||
|
“Pharmacodynamic monitoring of molecular cancer therapeutics at the preclinical and early clinical stages of development” - David W Hedley, MD, Dept. of Medical Oncology and Hematology, Division of Experimental Therapeutics, Princess Margaret Hospital/Ontario Cancer Institute, University of Toronto |
|||
|
“Changing Times - Changing Paradigms: The Role of Quantitative Imaging Cytometry in Extracting Maximal Information from Minimal Material “ - William Geddie, MD, Department of Laboratory Medicine and Pathobiology, University of Toronto, Cytopathologist, University Health Network |
|||
|
| |||